Alzheimer’s Eli Lilly

Showing 1 posts of 1 posts found.


Eli Lilly’s solanezumab fails at Phase 2/3 in early-onset Alzheimer’s disease

February 11, 2020
Manufacturing and Production Alzheimer's Eli Lilly, pharma, trial failure

In another blow to Alzheimer’s research, it has emerged that a study investigating Eli Lilly’s solanezumab in the treatment of …

Latest content